The Tide owner's quarterly volume was flat for the second consecutive quarter. Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly. [Read more]
Spain's Deoleo says the industry must undergo a "profound transformation" as it grapples with one of the most challenging moments in its history. [Read more]
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine. [Read more]
Sony and Apollo showed formal interest in a Paramount Global buyout as Paramount's special committee is prepared to give its recommendation to Skydance. [Read more]
